Evidence map›Paper›PMID 37792075›Full record

SynthesisNeuropsychology review2024

Behavioral Treatment for Speech and Language in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech: A Systematic Review.

Lisa D Wauters, Karen Croot, Heather R Dial, Joseph R Duffy, Stephanie M Grasso, Esther Kim, Kristin Schaffer Mendez, Kirrie J Ballard, Heather M Clark, Leeah Kohley and 5 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Neuropsychology review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Communication Bridge-2 randomized controlled trial: Recruitment and baseline features.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Lisa D Wauters *Department of Speech, Language, and Hearing Sciences, University of Texas at Austin, 2504A Whitis Ave. (A1100), 78712, Austin, TX, USA.ORCID http://orcid.org/0000-0001-8191-9366
Karen Croot *School of Psychology, University of Sydney, 2006, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9459-2913
Heather R DialDepartment of Communication Sciences and Disorders, University of Houston, Houston, TX, 77204, USA.ORCID http://orcid.org/0000-0003-3487-9183
Joseph R DuffyDepartment of Neurology, Division of Speech Pathology, Mayo Clinic, Rochester, MN, 55902, USA.ORCID http://orcid.org/0000-0001-8206-3432
Stephanie M GrassoDepartment of Speech, Language, and Hearing Sciences, University of Texas at Austin, 2504A Whitis Ave. (A1100), 78712, Austin, TX, USA.ORCID http://orcid.org/0000-0001-5287-3012
Esther KimUS Department of Communication Sciences and Disorders, Faculty of Rehabilitation Medicine, University of Alberta, T6G 2R3, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0003-3748-7310
Kristin Schaffer MendezThe University of St. Augustine, Austin, TX, 78712, USA.ORCID http://orcid.org/0000-0002-7342-9225
Kirrie J BallardFaculty of Medicine & Health and Brain & Mind Centre, University of Sydney, Sydney, NSW, 2006, Australia.ORCID http://orcid.org/0000-0002-9917-5390
Heather M ClarkDepartment of Neurology, Division of Speech Pathology, Mayo Clinic, Rochester, MN, 55902, USA.ORCID http://orcid.org/0000-0001-9697-0084
Leeah KohleyDepartment of Speech, Language, and Hearing Sciences, University of Texas at Austin, 2504A Whitis Ave. (A1100), 78712, Austin, TX, USA.ORCID http://orcid.org/0000-0003-3606-7146
Laura L MurraySchool of Communication Sciences and Disorders, Western University, London, ON, N6A 3K7, Canada.ORCID http://orcid.org/0000-0002-7773-1843
Emily J RogalskiDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Feinberg School of Medicine, 60611, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6472-1363
Mathieu FigeysFaculty of Rehabilitation Medicine, University of Alberta, Edmonton, AB, T6G 2R3, Canada.ORCID http://orcid.org/0000-0002-7101-689X
Lisa MilmanDepartment of Communicative Disorders and Deaf Education, Utah State University, Logan, UT, 84322, USA.
Maya L HenryDepartment of Speech, Language, and Hearing Sciences, University of Texas at Austin, 2504A Whitis Ave. (A1100), 78712, Austin, TX, USA. maya.henry@austin.utexas.edu.ORCID http://orcid.org/0000-0002-8745-6451
The University of Texas at Austin · USMayo Clinic · USThe University of Sydney · AUUniversity of Alberta · CANorthwestern University · USUniversity of Houston · USUniversity of St. Augustine for Health Sciences · USUtah State University · USWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary progressive aphasia (PPA) and primary progressive apraxia of speech (PPAOS) are neurodegenerative syndromes characterized by progressive decline in language or speech. There is a growing number of studies investigating speech-language interventions for PPA/PPAOS. An updated systematic evaluation of the treatment evidence is warranted to inform best clinical practice and guide future treatment research. We systematically reviewed the evidence for behavioral treatment for speech and language in this population. Reviewed articles were published in peer-reviewed journals through 31 May 2021. We evaluated level of evidence, reporting quality, and risk of bias using a modified version of the American Speech-Language Hearing Association (ASHA) Levels of Evidence, an appraisal point system, additional reporting quality and internal/external validity items, and, as appropriate, the Single Case Experimental Design Scale or the Physiotherapy Evidence Database - PsycBITE Rating Scale for Randomized and Non-Randomized Controlled Trials. Results were synthesized using quantitative summaries and narrative review. A total of 103 studies reported treatment outcomes for 626 individuals with PPA; no studies used the diagnostic label PPAOS. Most studies evaluated interventions for word retrieval. The highest-quality evidence was provided by 45 experimental and quasi-experimental studies (16 controlled group studies, 29 single-subject designs). All (k = 45/45) reported improvement on a primary outcome measure; most reported generalization (k = 34/43), maintenance (k = 34/39), or social validity (k = 17/19) of treatment for at least one participant. The available evidence supports speech-language intervention for persons with PPA; however, treatment for PPAOS awaits systematic investigation. Implications and limitations of the evidence and the review are discussed.

Indexed as

Aphasia, Primary ProgressiveApraxiasBehavior TherapyHumansLanguage TherapySpeech TherapyFrontotemporal dementiaPrimary progressive aphasiaPrimary progressive apraxia of speechSemantic dementiaSpeech therapySystematic review

Identifiers

PMID37792075
PMCPMC11473583
OpenAlexW4387326413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.